BVMF/PFRM3 (BVMF/PFRM3)

Brazil Stock Exchange: BVMF/PFRM3 · BRL

R$6.46

-0.14 (-2.1%)· Recorded snapshot

Market cap	792.1M
Revenue (ttm)	12.5B
Net income (ttm)	154.5M
EPS (ttm)	R$1.26
Shares out	122.6M
P/E (trailing)	5.1x
Dividend	R$0.58 (8.90%)
Volume	1,700
Beta	0.33

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 12.5B
Net income (ttm): 154.5M
EPS (ttm): R$1.26
P/E (trailing): 5.1x
Market cap: 792.1M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 13:30 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E5.1

P25 n/aP50 n/aP75 n/a

ROE9.8

P25 n/aP50 n/aP75 n/a

ROIC10.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/PFRM3 indicators

Market & fundamental data

Available fields

247

Groups with data

Currency

BRL

Showing 247 of 247 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	Brazil
Country code	BR
Earnings date	2026-11-12
Employees	7,077
Employees change	159
Employees growth	2.3%
Enterprise value	BRL 2.4B
Exchange	Brazil Stock Exchange
Financial currency	BRL
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1961
Industry	Medical Distribution
Is primary listing	Yes
ISIN number	BRPFRMACNOR1
Last earnings date	2026-07-29
Last refreshed	2026-10-30
Market cap	BRL 792.1M
Next earnings date	2026-11-12
Price	BRL 6.46
Price currency	BRL
Sector	Healthcare
SIC code	5122
Stock price date	2026-10-30
Symbol	bvmf/PFRM3
Website	https://www.profarma.com.br

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	12.74x
Average P/E ratio (3Y)	8.31x
Average P/E ratio (5Y)	8.07x
Earnings yield	19.5%
EV/Earnings	15.93x
EV/EBIT	6.71x
EV/EBITDA	4.45x
EV/FCF	6.01x
EV/Sales	0.2x
FCF / EV yield	16.64%
FCF yield	50.62%
Graham number	18.26516
Graham upside	176.74%
Lynch fair value	BRL 11.85
Lynch upside	79.52%
P/B ratio	0.48x
P/E ratio	5.13x
P/FCF ratio	1.98x
P/OCF ratio	1.41x
P/S ratio	0.06x
Price / tangible book value	1.09x
Price/EBITDA ratio	1.91x
Sector forward P/E	11.07x
Sector P/E	40.53x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	2.94%
EBITDA margin	3.39%
Effective tax rate	13.47%
FCF margin	3.28%
Gross margin	15.14%
Operating margin	2.94%
Pretax margin	1.49%
Profit margin	1.24%
Profit per employee	BRL 21,837
Profitable quarters	1
Profitable years	7
Revenue per employee	BRL 1.8M
ROA	3.43%
ROA (5Y)	3.31%
ROCE	9.6%
ROE	9.75%
ROE (5Y)	6.38%
ROIC	10.57%
ROIC (5Y)	10.33%
Tax / revenue	0.2%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	30.98%
EPS growth (Q)	225.36%
EPS growth 3Y	71.34%
EPS growth 5Y	9.4%
EPS growth quarters	1
EPS growth years	2
FCF growth	63.79%
FCF growth 3Y	20.1%
Gross profit growth	15.44%
Gross profit growth (Q)	22.96%
Gross profit growth 3Y	15.86%
Gross profit growth 5Y	17.47%
Net income growth	30.95%
Net income growth (Q)	225.36%
Net income growth 3Y	71.35%
Net income growth 5Y	9.4%
Net income growth quarters	1
Net income growth years	2
OCF growth	54.77%
OCF growth (QoQ)	-66.63%
OCF growth 3Y	25.23%
Operating income growth	18.19%
Operating income growth (Q)	10.84%
Operating income growth 3Y	19.51%
Operating income growth 5Y	19.79%
Revenue growth	13.2%
Revenue growth (Q)	32.39%
Revenue growth (QoQ)	24.47%
Revenue growth 10Y	12.7%
Revenue growth 3Y	14.63%
Revenue growth 5Y	16.22%
Revenue growth quarters	32
Revenue growth years	11

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -163.5M
Depreciation and amortization	BRL 56.5M
EBIT	BRL 366.9M
EBITDA	BRL 423.5M
EPS	BRL 1.26
FCF per share	BRL 3.34
Financing cash flow	BRL -142.6M
Free cash flow	BRL 409.6M
Gross profit	BRL 1.9B
Income taxes	BRL 25.1M
Investing cash flow	BRL -189.3M
Net borrowing	BRL 154.5M
Net cash flow	BRL 241.2M
Net income	BRL 154.5M
Operating income	BRL 366.9M
Revenue	BRL 12.5B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.08
Book value per share	BRL 11.77
Debt / EBITDA	3.43
Debt / equity	1.13
Debt / FCF	4.63
Goodwill	BRL 476.1M
Interest coverage	1.58
Long-term assets	BRL 2.3B
Long-term liabilities	BRL 2.1B
Net cash (debt)	BRL -1.4B
Net cash / market cap	-174.26%
Net debt / EBITDA	3.33
Net debt / equity	0.84
Net debt / FCF	3.44
Piotroski F-Score	6
Property, plant and equipment	BRL 894.6M
Shareholders' equity	BRL 1.7B
Tangible book value	BRL 742.9M
Tangible book value per share	BRL 6.06
Total assets	BRL 8B
Total cash	BRL 487.8M
Total debt	BRL 1.9B
Total liabilities	BRL 6.3B
WACC	9.26%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.87
Current assets	BRL 5.7B
Current liabilities	BRL 4.2B
Current ratio	1.37
Inventory turnover	5.62
Net working capital	BRL 1.8B
Quick ratio	0.79
Working capital	BRL 1.6B
Working capital turnover	10.35

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend growth	31.83%
Dividend growth (10Y)	16.63%
Dividend growth (3Y)	63.54%
Dividend growth (5Y)	22.88%
Dividend growth years	2
Dividend payment date	2026-01-15
Dividend payment years	6
Dividend per share	BRL 0.58
Dividend yield	8.9%
Ex-dividend date	2026-01-02
FCF payout ratio	19.29%
Last dividend	BRL 0.32
Payout ratio	51.12%
Shareholder yield	8.71%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-39.56%
10Y return CAGR	-1.57%
10Y total return	-14.68%
150-day SMA	BRL 7.34
15Y price change	-39.39%
15Y return CAGR	-0.53%
15Y total return	-7.63%
1D price change	-2.12%
1M price change	-8.21%
1M total return	-8.21%
1W price change	-29.41%
1W total return	-29.41%
1Y price change	-9.47%
1Y return CAGR	-2.39%
1Y total return	-2.39%
20-day SMA	BRL 8.56
200-day SMA	BRL 7.65
20Y price change	-73.6%
20Y return CAGR	-4.22%
20Y total return	-57.82%
3M price change	5.6%
3M total return	5.6%
3Y price change	91.3%
3Y return CAGR	32.89%
3Y total return	134.71%
50-day SMA	BRL 7.93
50-day SMA vs 200-day SMA	50over200
52-week high	BRL 9.70
52-week high date	2026-01-29
52-week low	BRL 6.11
52-week low date	2026-07-27
5Y price change	36.08%
5Y return CAGR	12.75%
5Y total return	82.18%
6M price change	-17.4%
6M total return	-17.4%
All-time high	BRL 40.90
All-time high date	2007-02-02
All-time low	BRL 2.87
All-time low date	2020-03-23
Average true range (ATR)	BRL 0.52
Average volume	306K
Beta (1Y)	0.11
Beta (2Y)	0.16
Beta (5Y)	0.33
Change from 52-week high	-33.4%
Change from 52-week low	5.73%
Change from all-time high	-83.86%
Change from all-time low	129.97%
Change from open	-2.12%
Day's gap	0%
Dollar volume	BRL 10,982
High price	BRL 6.60
Low price	BRL 6.46
Monthly RSI	44.97
Open price	BRL 6.60
Position in 52-week range	0%
Previous close	BRL 6.60
Price vs 150-day SMA	-10.13%
Price vs 20-day SMA	-22.93%
Price vs 200-day SMA	-13.67%
Price vs 50-day SMA	-16.72%
Relative volume	0.01
RSI	28.11
Sharpe ratio	0.22
Sharpe ratio (3Y)	0.72
Sharpe ratio (5Y)	0.32
Sortino ratio	0.4
Sortino ratio (3Y)	1.19
Sortino ratio (5Y)	0.6
Volume	1.7K
Weekly RSI	42.38
YTD price change	-27.71%
YTD total return	-25.1%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	29.4M
Shares change (QoQ)	0%
Shares held by insiders	2.45%
Shares held by institutions	3.9%
Shares outstanding	122.6M

Deeper analysis on BVMF/PFRM3

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/PFRM3 report

Is a complete BVMF/PFRM3 research report available?

No complete published report is available for bvmf/PFRM3 (BVMF/PFRM3) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/PFRM3 (BVMF/PFRM3)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/PFRM3

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/PFRM3 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/PFRM3

Frequently asked questions